GliPR1 knockdown by RNA interference exerts anti‐glioma effects in vitro and in vivoUrban Scheuring(AstraZeneca (United Kingdom)), Stefanie Tietze(University Hospital Carl Gustav Carus)Journal of Neuro-OncologyApril 15, 202110.1007/s11060-021-03737-3Cited by 9SaveCiteExport RISWatch citationsRelated PapersClinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia|Blood|2005|537NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC|Journal of Thoracic Oncology|2022|72